Influence of Survivorship Care on Health‐Related Quality of Life, Knowledge of Late Effects, and Distress Levels Among Long‐Term Hodgkin Lymphoma Survivors
Cancer Medicine · 2025
DOI: 10.1002/cam4.71113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Eline M J Lammers und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Hodgkin Disease, Quality of Life, Cancer Survivors, Survivorship. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Ministerie van Volksgezondheid, Welzijn en Sport, KWF Kankerbestrijding.
Abstract (Originalsprache)
Introduction
Hodgkin lymphoma (HL) is a highly curable malignancy mainly affecting young adults, but survivors are at risk of serious late adverse effects, like cardiovascular disease and subsequent malignancies, which may impact health‐related quality of life (HRQoL). The Dutch BETER consortium introduced a nationwide survivorship care program offering tailored screening for late effects among HL survivors from 5 years after diagnosis onward. This study evaluates the association between BETER survivorship care and HRQoL, knowledge of late effects, and distress levels.
Methods
The INSIGHT study is a nationwide retrospective cohort study comparing HL survivors who received BETER care since 2013‐2016 to matched survivors who did not receive survivorship care until 2019–2024. HRQoL was cross‐sectionally assessed in 2021–2024 (median time since HL diagnosis ~25 years) using the SF‐36 and EQ‐5D‐5L questionnaires. Knowledge of late effects and distress levels were evaluated using a modified Cancer Worry Scale and a 15‐item knowledge questionnaire. Multivariable negative binomial regression analyses were performed to compare outcomes between groups.
Results
HRQoL outcomes showed no significant differences between survivors screened since 2013‐2016 ( n = 251) and the comparison group ( n = 119). Overall, HRQoL of HL survivors matched that of the general population in the Netherlands. Knowledge of late effects was suboptimal in both groups, and distress levels were similarly low. Eighty percent of survivors perceived BETER care as beneficial, with most individuals stating that increased knowledge outweighed potential worries.
Conclusion
BETER survivorship care was not associated with better HRQoL among long‐term HL survivors, but the care was perceived as beneficial by survivors. Future (qualitative) research could focus on survivors' preferences for education about their risk of late effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands.
- Department of Radiation Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Hematology, Haaglanden Medical Center, Location Antoniushove, Leidschendam, the Netherlands.
- Department of Radiation Oncology, Institute Verbeeten, Tilburg, the Netherlands.
ORCID-Profile: Eline M J Lammers
Förderung
- ZonMw
- Ministerie van Volksgezondheid, Welzijn en Sport
- KWF Kankerbestrijding
Zitieren
APA
Lammers, E. M. J., Nijdam, A., Schaapveld, M., van de Poll-Franse, L. V., Janus, C. P. M., Aarsman, K. M., Te Boome, L. C. J., Tomasoa, N. B., Boersma, R. S., Rademakers, S. E., Stedema, F. G., Böhmer, L. H., van den Berg, M., Kroeze, A. C., Strobbe, L. S., Deenik, W., de Lil, H. S., van Leeuwen, F. E., Aleman, B. M. P., …, & BETER consortium (2025). Influence of Survivorship Care on Health‐Related Quality of Life, Knowledge of Late Effects, and Distress Levels Among Long‐Term Hodgkin Lymphoma Survivors. Cancer Medicine. https://doi.org/10.1002/cam4.71113
Vancouver
Lammers EMJ, Nijdam A, Schaapveld M, van de Poll-Franse LV, Janus CPM, Aarsman KM, et al. Influence of Survivorship Care on Health‐Related Quality of Life, Knowledge of Late Effects, and Distress Levels Among Long‐Term Hodgkin Lymphoma Survivors. Cancer Medicine. 2025. doi:10.1002/cam4.71113
BibTeX
@article{Lammers2025,
author = {Lammers, Eline M J and Nijdam, Annelies and Schaapveld, Michael and van de Poll-Franse, Lonneke V and Janus, Cécile P M and Aarsman, Karin M and Te Boome, Liane C J and Tomasoa, Nathalie B and Boersma, Rinske S and Rademakers, Saskia E and Stedema, Floriske G and Böhmer, Lara H and van den Berg, Marieke and Kroeze, Adriaantje C and Strobbe, Leonie S and Deenik, Wendy and de Lil, Heleen S and van Leeuwen, Flora E and Aleman, Berthe M P and Zijlstra, Josée M and BETER consortium, BETER consortium},
title = {Influence of Survivorship Care on Health‐Related Quality of Life, Knowledge of Late Effects, and Distress Levels Among Long‐Term Hodgkin Lymphoma Survivors},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71113}
}
EUVIMED